Compare LNTH & RRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LNTH | RRC |
|---|---|---|
| Founded | 1956 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 10.9B |
| IPO Year | 2014 | 1996 |
| Metric | LNTH | RRC |
|---|---|---|
| Price | $75.79 | $43.48 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 17 |
| Target Price | ★ $83.20 | $43.18 |
| AVG Volume (30 Days) | 1.0M | ★ 3.4M |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 0.89% |
| EPS Growth | N/A | ★ 151.38 |
| EPS | ★ 3.41 | 2.74 |
| Revenue | $343,374,000.00 | ★ $3,115,515,000.00 |
| Revenue This Year | N/A | $13.16 |
| Revenue Next Year | $13.93 | $9.96 |
| P/E Ratio | $22.25 | ★ $16.47 |
| Revenue Growth | 3.62 | ★ 28.90 |
| 52 Week Low | $47.27 | $30.32 |
| 52 Week High | $108.86 | $48.31 |
| Indicator | LNTH | RRC |
|---|---|---|
| Relative Strength Index (RSI) | 50.90 | 51.07 |
| Support Level | $72.33 | $34.07 |
| Resistance Level | $84.77 | $43.50 |
| Average True Range (ATR) | 2.70 | 1.64 |
| MACD | -0.69 | -0.22 |
| Stochastic Oscillator | 31.10 | 22.03 |
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Range Resources is an exploration and production firm whose operations represent a pure play in the Marcellus shale, located in the Appalachian region of Southwest Pennsylvania. The company went public as Lomak Petroleum in 1980 and later reorganized as Range Resources in 1998. After an expensive 10-year venture with a multi-basin strategy, Range Resources found its identity as an Appalachian natural gas producer, offloading its Permian assets in 2013. Range quickly became a leading US gas producer after its merger with Memorial Resource Development in 2016. Following the merger, Range saw its operational unit costs rise to an uncompetitive level and subsequently sold the assets in 2020 to return to its roots as an Appalachian producer.